Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa
- 19 June 2013
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 97 (9), 1187-1191
- https://doi.org/10.1136/bjophthalmol-2012-303005
Abstract
To evaluate the therapeutic effect of continuous treatment with topical dorzolamide (a carbonic anhydrase inhibitor) for cystoid macular oedema (CME) associated with retinitis pigmentosa (RP). 18 eyes in 10 patients with CME secondary to RP were included. Baseline visual acuity, visual field and optical coherence tomography (OCT) measurements were obtained for all patients. All patients used 1% dorzolamide three times daily in each affected eye. Patients underwent follow-up examinations at 1, 3, 6, 12 and 18 months after treatment. The response to treatment was monitored by the Humphrey field analyser (HFA: the central 10-2 program); in addition, foveal thickness was measured by OCT. Evaluation of 'macular sensitivity' was calculated by HFA as the average of 12 central points. The 'macular sensitivity' in 10 eyes in which CME was almost completely resolved was significantly improved (p<0.05). In eight of the nine eyes in which CME was almost completely resolved within 6 months, the therapeutic efficacy persisted through 18 months. Five eyes which were almost completely resolved or showed an initial response within 6 months experienced recurrence of CME. The prolonged (longer than 1 year) use of topical dorzolamide is effective for the treatment of CME in patients with RP. Therefore, we propose topical dorzolamide treatment as a first choice.Keywords
This publication has 18 references indexed in Scilit:
- Intravitreal Bevacizumab (Avastin) Injection in Retinitis PigmentosaCurrent Eye Research, 2009
- Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosaBritish Journal of Ophthalmology, 2007
- Topical Dorzolamide for the Treatment of Cystoid Macular Edema in Patients With Retinitis PigmentosaAmerican Journal of Ophthalmology, 2006
- Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosaActa Ophthalmologica Scandinavica, 2005
- Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosaOphthalmology, 2003
- Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosaNature, 1991
- Genetic analysis of patients with retinitis pigmentosa using a cloned cDNA probe for the human gamma subunit of cyclic GMP phosphodiesteraseExperimental Eye Research, 1991
- A point mutation of the rhodopsin gene in one form of retinitis pigmentosaNature, 1990
- Treatment of Chronic Macular Edema With AcetazolamideAmerican Journal of Ophthalmology, 1988
- Foveal Lesions Seen in Retinitis PigmentosaAmerican Journal of Ophthalmology, 1977